Such a terrifying drug will cause great damage to the world if it is obtained by terrorist organizations or individuals. If a country enjoys this technology exclusively, it will greatly increase the country's combat effectiveness.

Chen Ning did not want to attract the attention of the Chinese military. He discussed with Chen Hongsheng that Niu Niu had greatly reduced the efficacy of the "trauma ointment" and minimized the side effects of the "trauma ointment".

The result is that the "trauma ointment" has abandoned the original formula and turned into a brand new trauma treatment drug. Of course, the premise is to be produced based on the existing traditional Chinese medicine on the earth as the raw material, and Niu Niu is required to divide the efficacy into three levels, namely 1/10, 1/20, and 1/100 of the original formula. The three ointments with different therapeutic effects are named after different drugs.

The ointment with one percent effect of the original formula is named "Sistine-Growing Ointment", which can completely heal the wounds that do not hurt the internal organs within half an hour; the ointment with one percent effect of the original formula is named "Hemostatic Ointment", which can stop bleeding and heal the permeable wounds within 20 minutes; the ointment with one percent effect of the original medicine is used to continue using the original name "Wound Ointment", which is already a special drug at the level of magical medicine under the current conditions of the earth. Chen Ning intends to limit the production of "Wound Ointment", and after production, part of it will be used as a stock and will not be put on the market.

On March 28, "Liaodong Xingkong Biopharmaceutical Co., Ltd." was officially established, and at the same time, the first batch of 20,000 experimental drugs for cancer antibiotics "probiotics" were packed into the warehouse. Three ointments for treating trauma also produced 20,000 experimental drugs each. Liaodong Xingkong Biopharmaceutical Co., Ltd. immediately sent preclinical research reports on four drugs and ointments, process research reports on raw materials and preparations, quality research reports on raw materials and preparations, and quality research reports on raw materials and preparations, and at the same time applied for clinical research to the State Food and Drug Administration. A few hours after the report was submitted, the Provincial Food and Drug Administration and the National Food and Drug Administration websites "approved" Liaodong Xingkong Biopharmaceutical Co., Ltd. for "probiotics", and the three trauma ointments were applied for phase 1 clinical trials. Chen Ning immediately sent someone to the capital to collect the approval documents and clinical trial approval documents.

At 10 a.m. on March 29, Liaodong Xingkong Biopharmaceutical Co., Ltd. held a press conference at the Fengjing Marriott Hotel, and announced the following information to the reporters attending the reception:

After several years of experimental research, the company has successfully developed a special antibiotic "probiotic" for the treatment of cancer.

"Probiotics" are 100% effective in early-stage patients with cancer and 99% effective in advanced-stage patients with cancer.

Spokesperson Ms. Chen Qiuyu explained that this is 99% effective. If cancer patients do not have organic failure or organ necrosis, the therapeutic effect of "probiotics" is 100% cured and will not recur.

The company will recruit 100 advanced cancer volunteers from countries around the world and participate in the company's clinical trials. Among them, the limit for China is 40, the limit for other Asian countries is 20, the limit for Europe is 15, the limit for America is 15, and the limit for Africa and Australia is 10.

Each cancer patient participating in the clinical trial can be accompanied by a relative and a well-known media reporter at the patient's location. He needs to bring a medical signature for examination and treatment in a well-known medical institution in the country. The company is allowed to announce it to the public.

Liaodong Xingkong Biopharmaceutical Co., Ltd. is responsible for the flight tickets between three people and the accommodation costs in Fengjing, and ensures that the patients are fully recovered, and the treatment is 100% effective. Those who are ineffective will receive 100,000 US dollars.

Liaodong Xingkong Biopharmaceutical Co., Ltd. will book a four-star "Lidu Hotel" near Fengjing Pharmaceutical Factory, as the accommodation for the patient ward and accompanying staff, and the reporter.

Liaodong Xingkong Biopharmaceutical Co., Ltd. will apply to the World Health Organization and the State Administration of China to send personnel to guide and supervise the clinical trial. At the same time, peers or well-known hospitals are welcome to send experts and scholars to Liaodong Xingkong Biopharmaceutical Co., Ltd. to observe and supervise the entire treatment process throughout.

Registerers please log in to the company's official website. http://www./.

Since "Liaodong Xingkong Biopharmaceutical Co., Ltd." is just a newly established small company and is unknown. Therefore, there are very few reporters coming to participate in this press conference, only the eight young people of Liao Ruochenxing.

However, Ms. Chen Qiuyu, who served as the company's spokesperson, was not disappointed because of the small number of reporters, nor did she neglect these young reporters who gave the company face. She completed the press conference step by step according to the reception procedures.

After the press conference, Ms. Chen Qiuyu gave each of the young reporters present a special company card on behalf of the company.

The card promised that the company would treat the card holders free of charge, with the limit of cure. The eight reporters who received the card were very disappointed that Starry Sky Company did not pay the bill and decided not to report the news, or just give a title message without content.

Three of them felt that the content of the card was unlucky. After walking out of the reception venue, they threw the card into the garbage can next to the door. The huge pie landed unexpectedly on Aunt Zhang, a 50-year-old cleaning lady at the Marriott Hotel, who was cleaning the garbage at the time.

Seeing that the cards thrown away by the three of them were exquisitely made, Aunt Zhang put three special cards into a card holder with only one bank deposit value card, filling the card holder so that the card holder did not look shabby. Her unintentional act to satisfy her vanity made her family get rid of poverty a month later, and bought more than 100 square meters of real estate and a Volkswagen off-road vehicle worth hundreds of thousands of yuan each for herself and her soon-to-be-married son.

When "probiotics" were at its peak, these eight-game incidents made headlines in Fengjing Evening News and were reprinted by various print media, TV media and online media, becoming a legend of street talks.

The three journalists who threw away the special card casually were named "the number one fool in history" by those who were informed. They lived in regret every day, which greatly affected their jobs. In the next year, one reporter resigned and could not bear the psychological pressure, and the other two journalists also changed their careers and stopped being journalists.

Less than an hour after the press conference, major comprehensive websites, medical professional websites and famous medical institutions were "reprinted" by "Starry Pharmaceutical Company" to successfully develop a special drug "probiotic" for cancer treatment, as well as detailed content of the company's recruitment of volunteers for advanced cancer from countries around the world.
Chapter completed!